The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transition, invasion and metastasis of pancreatic cancer cells

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study

Giuseppe Colucci, Roberto Labianca, Francesco Di Costanzo et al. · Journal of Clinical Oncology · 2010 · 301 citations · Full text

Medicine, Oncology, Pharmacology +13

First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial

Cesare Gridelli, Fortunato Ciardiello, Ciro Gallo et al. · Journal of Clinical Oncology · 2012 · 234 citations · Full text

Medicine, Oncology, Pharmacology +16

Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial

Francesco Cognetti, Enzo Maria Ruggeri, Alessandra Felici et al. · Annals of Oncology · 2011 · 220 citations · Full text

Medicine, Oncology, Urology +13

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Anthony Gonçalvès, Marine Gilabert, E. François et al. · Annals of Oncology · 2012 · 214 citations · Full text

Medicine, Oncology, Pharmacology +7

Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: a Phase 2 Study

Jeffrey M. Hardacre, Mary F. Mulcahy, William Small et al. · Journal of Gastrointestinal Surgery · 2012 · 202 citations

Medicine, Immunology, Oncology +12